Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain ...

“Not every patient with sickle cell disease will be eligible for gene therapy, so blood transfusions will remain crucial. Some patients don’t have complications severe enough to require gene therapy, ...

After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...

Currently, kidney transplantation is the most effective treatment to ensure survival and improve the quality of life of ...

Results from a preclinical study in mice and a collaborative clinical study in patients show that the type 2 immune response -- associated with parasitic infection and thought to play a negative role ...

Rahul Banerjee, MD, FACP, assistant professor in the Division of Hematology and Oncology, University of Washington, dissects the limited data on T-cell therapies for multiple myeloma, infectious ...

The company said benefits no longer outweighed the risks, with data suggesting the drug might increase the risk of pain ...

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

Baytown native, Kaylyn White, is the newest volunteer at Houston-based animal rescue, Waiting Under the Willow Foundation.

A 45-year-old woman was evaluated in the rheumatology clinic because of possible IgG4-related disease. She had polyclonal ...

Lyric Porter’s battle with sickle cell began almost immediately after birth. Here's how a groundbreaking treatment improved ...